Flow analysis of tumor-derived CD45+ leukocytes demonstrated a significant reduction in the frequency of F4/80+ and CD11b+F4/80+ TAMs in DMBA3-4 compared with DMSO3-1 tumors (Figure 4, A–C). The gene discussed is ITGAM; the disease is neoplasm.